But he said he is also concerned about the fact that, for compounders, its challenging to get the right ingredients. And, as a result, human beings are injecting themselves with versions of GLP-1 drugs meant for laboratory studies, which, Aggarwal said, could be harmful. At the end of the day, these are real humans we are taking care of, he said
Prescribing outside the licensed indications and doses constitutes off-label use, which requires prescribers to document their rationale, obtain informed consent, and provide appropriate monitoring
The program & eligibility GLP1 + GIP can be appropriate for many seniors when prescribed and supervised by a licensed provider
1:100) and for glucagon using a monoclonal anti-rabbit antibody (Santa Cruz Biotechnology, SC-7779R